Waters Corporation Trading Volume Drops 47.71% to $399 Million, Ranks 251st as $17.5 Billion Acquisition Announced

On July 16, 2025, Waters Corporation (WAT) closed at a trading volume of $399 million, marking a 47.71% decrease from the previous day. This placed Waters at the 251st position in terms of trading volume for the day.

Waters Corporation has announced a significant acquisition, valued at $17.5 billion, to acquire BD's flow cytometry business. This business is renowned for developing instruments used in clinical testing and medical research. The acquisition is part of a broader strategic move by BD to spin off its biosciences and diagnostics businesses, aiming to become a pure-play medtech company. The transaction is structured as a tax-efficient Reverse Morris Trust, with the combined entity expected to generate approximately $6.5 billion in sales and $2.0 billion in adjusted EBITDA for 2025. This merger is anticipated to create a diagnostics powerhouse, targeting $9 billion in revenues by 2030. The deal underscores Waters' commitment to expanding its capabilities in life sciences and diagnostics, positioning the company for long-term growth and innovation in the healthcare sector.